Dr. Mrittika Sen

Fellow, Department of Ocular Oncology and Ophthalmic and Facial Plastic Surgery, Centre for Sight Superspeciality Eye Hospital, Hyderabad.

1 article

Dr Mrittika Sen completed her medical education from Seth G.S. Medical College and K.E.M. Hospital in Mumbai with distinction in seven subjects. She went on to do her post-graduation from Dr R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi. She is currently pursuing her fellowship in Ophthalmic Plastic Surgery and Ocular Oncology at the Centre for Sight Superspeciality Eye Hospital, Hyderabad. She has presented at various national and international conferences including APAO, ISOO, AAO, OPAI and AIOS. She has also published papers in many journals and contributed chapters in many books on ophthalmology. Mentionable among them are her chapter on orbital implants in the textbook of Oculoplasty Surgery: A Practical Guide to Common Disorders and the review article on Coats Disease, published in the Indian Journal of Ophthalmology, which was awarded the AIOS-IJO Silver Award for the year 2019.

  1. Articles 1 Apr 2021 8 min read

    Retinoblastoma : Top Ten Tenets for an Ophthalmologist

    1.Common and Curable Retinoblastoma is the most common childhood ocular malignancy. Annually there are about 6000 new cases worldwide. It is most commonly diagnosed at 15-18 months of age although in developing countries, older children also present with the disease. It is potentially curable if detected early and with proper management. Currently, the survival rate is as high as 95% with 90% eye salvage and 85% vision salvage. 2 The root of the Family Tree Retinoblastoma can be associated with germline mutation or somatic mutations of the RB1 gene on the long arm of chromosome 13. Heritable retinoblastoma constitutes 30-40% of all retinoblastomas while the rest are non- heritable. 25% of the germline mutations are familial with autosomal dominant inheritance and the remaining occur de novo. In heritable retinoblastoma, patients are prone to other second primary neoplasia including pinealoblastoma, osteosarcoma and soft tissue sarcomas. Genetic testing for germline mutations are availa

    Dr. Mrittika Sen · Dr. Santosh G Honavar, MD, FACS